Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Resch, B; Manzoni, P; Lanari, M.
Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes.
Paediatr Respir Rev. 2009; 10(3): 148-153. Doi: 10.1016/j.prrv.2009.06.003
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Resch Bernhard
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infection (LRTI) in infants and children. There is growing evidence of severe RSV disease in infants with neuromuscular diseases and immune deficiency syndromes. Factors predisposing to a more severe course of RSV disease in neuromuscular diseases include the impaired ability to clear secretions from the airways due to ineffective cough, respiratory muscle weakness, high prevalence of gastro-oesophageal reflux and swallowing dysfunction which leads to aspiration. Similarly, pulmonary disease is a common presenting feature and complication of T-cell immunodeficiency. Infants with severe congenital and acquired immune deficiency syndromes may demonstrate prolonged viral shedding in RSV LRTI and are reported to have increased morbidity and mortality associated with RSV infection. Although not indicated in most guideline statements, palivizumab prophylaxis for these uncommon underlying conditions is under consideration by clinicians. Prospective studies are needed to determine the burden of RSV disease in these children.
Find related publications in this database (using NLM MeSH Indexing)
Comorbidity -
Humans -
Immunologic Deficiency Syndromes - epidemiology
Infant -
Neuromuscular Diseases - epidemiology
Respiratory Syncytial Virus Infections - epidemiology
Severe Combined Immunodeficiency - epidemiology

Find related publications in this database (Keywords)
respiratory syncytial virus
neuromuscular diseases
immune deficiency syndromes
lower respiratory tract infection
palivizumab
© Med Uni GrazImprint